Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide** (commonly known as W-7) is a synthetic small molecule that acts as a calmodulin antagonist. It features a naphthalene sulfonamide core with a chloro substituent at the 5-position and an aminohexyl side chain. W-7 binds to calmodulin, inhibiting its calcium-dependent activation of various enzymes and proteins, including calcium/calmodulin-dependent protein kinases. This compound is widely used in biochemical research to study calmodulin-mediated signaling pathways and the role of calcium in cellular processes[2][4][8]. It is not approved for clinical use but serves as an important tool compound in laboratory settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide.